Pharma Industry
Industry: Email Alert RSS FeedELI LILLY & CO.(forms Lilly Bio Ventures)(Brief Article)
Chemical Market Reporter, October, 2001
ELI LILLY & CO. has formed an early-stage biotech venture firm, Lilly Bio Ventures, with initial funding of $75 million. Also, the approval process for Xigris (recombinant human activated protein C), has been delayed following the postponement of an FDA advisory committee because of the recent terrorist attacks in Washington.
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
